| RT0269-25MG
| ReadyTag anti-DDDDK
| 25 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0075-5MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 5 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0174-25MG
| InVivoPlus anti-mouse LAG-3
| 25 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0085-100MG
| InVivoPlus mouse IgG2a isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0169-50MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 50 mg
| BioXCell
| in vivo activation of 4-1BB
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0010-5MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 5 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0088-25MG
| InVivoPlus rat IgG1 isotype control (anti-HRP)
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0117-25MG
| InVivoPlus anti-mouse CD8?
| 25 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0012-25MG
| InVivoSIM anti-human VEGFR-2 (Ramucirumab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, Immunohistochemistry, Flow cyto
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0239-100MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 100 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0307-25MG
| InVivoPlus anti-mouse CD16/CD32
| 25 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0268-5MG
| ReadyTag anti-HA
| 5 mg
| BioXCell
| ELISA, Western blot, Immunoprecipitation, Immunofl
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| IP0065-50ML
| InVivoPure pH 6.5 Dilution Buffer
| 50 ml
| BioXCell
| N/A
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| SIM0004-1MG
| InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar)
| 1 mg
| BioXCell
| CTLA-4 neutralization; Flow Cytometry; ELISA; West
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0066-50MG
| InVivoPlus anti-mouse Thy1.2 (CD90.2)
| 50 mg
| BioXCell
| in vivo ILC depletion, in vivo T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-5MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 5 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0014-100MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 100 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0011-5MG
| InVivoSIM anti-human C5 (Eculizumab Biosimilar)
| 5 mg
| BioXCell
| Inhibition of the activation of C5, Functional ass
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0263-25MG
| ReadyTag anti-c-myc
| 25 mg
| BioXCell
| Western blot, ELISA, Flow cytometry
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0007-50MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 50 mg
| BioXCell
| VEGF neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0117-5MG
| InVivoPlus anti-mouse CD8?
| 5 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-50MG
| InVivoPlus anti-mouse GITR
| 50 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0169-25MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 25 mg
| BioXCell
| in vivo activation of 4-1BB
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0061-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0266-5MG
| ReadyTag anti-6-His
| 5 mg
| BioXCell
| Western blot, Immunoprecipitation, Immunofluoresce
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| IPT080-50ML
| InVivoPure pH 8.0T Dilution Buffer
| 50 ml
| BioXCell
| N/A
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0173-5MG
| InVivoPlus anti-mouse IL-17A
| 5 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0213-50MG
| InVivoPlus anti-mouse CSF1R (CD115)
| 50 mg
| BioXCell
| in vivo macrophage depletion, in vitro CSF-R1 neut
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0009-5MG
| InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar)
| 5 mg
| BioXCell
| Flow Cytometry; Western blot
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| SIM0007-1MG
| InVivoSIM anti-human VEGF (Bevacizumab Biosimilar)
| 1 mg
| BioXCell
| VEGF neutralization; Flow Cytometry; ELISA; Immuno
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0283-5MG
| InVivoPlus anti-human/mouse/rat CD47
| 5 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0083-100MG
| InVivoPlus mouse IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| SIM0005-50MG
| InVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
| 50 mg
| BioXCell
| Flow Cytometry; ELISA; Immunohistochemistry; Weste
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0174-5MG
| InVivoPlus anti-mouse LAG-3
| 5 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0060-100MG
| InVivoPlus anti-mouse VEGFR-2
| 100 mg
| BioXCell
| in vivo blocking of VEGF/VEGFR-2 signaling, in vit
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0169-5MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 5 mg
| BioXCell
| in vivo activation of 4-1BB
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0086-100MG
| InVivoPlus mouse IgG2b isotype control
| 100 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0089-25MG
| InVivoPlus rat IgG2a isotype control
| 25 mg
| BioXCell
|
|
| Rat
| N/
| Solicitar Precio
| Solicitar
|
| BP0057-50MG
| InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-?
| 50 mg
| BioXCell
| in vivo TGF? neutralization, in vitro TGF? neutral
|
| Mouse
| mouse/human/rat/monkey/hamster/canine/bovin
| Solicitar Precio
| Solicitar
|
| SIM0012-5MG
| InVivoSIM anti-human VEGFR-2 (Ramucirumab Biosimilar)
| 5 mg
| BioXCell
| Functional assays, Immunohistochemistry, Flow cyto
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| BP0055-50MG
| InVivoPlus anti-mouse IFN?
| 50 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| RT0263-5MG
| ReadyTag anti-c-myc
| 5 mg
| BioXCell
| Western blot, ELISA, Flow cytometry
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0099-100MG
| InVivoPlus recombinant CTLA-4-Ig (hum./hum.)
| 100 mg
| BioXCell
|
|
| N/A
| N/
| Solicitar Precio
| Solicitar
|
| BP0239-5MG
| InVivoPlus anti-mouse CD137 (4-1BB)
| 5 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0086-5MG
| InVivoPlus mouse IgG2b isotype control
| 5 mg
| BioXCell
|
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|
| BP0283-100MG
| InVivoPlus anti-human/mouse/rat CD47
| 100 mg
| BioXCell
| in vivo CD47 blockade, in vitro CD47 blockade, Imm
|
| Mouse
| human/mouse/rat
| Solicitar Precio
| Solicitar
|
| BP0117-50MG
| InVivoPlus anti-mouse CD8?
| 50 mg
| BioXCell
| in vivo CD8+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0173-100MG
| InVivoPlus anti-mouse IL-17A
| 100 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| SIM0014-25MG
| InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar)
| 25 mg
| BioXCell
| Functional assays, ELISA
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
| RT0263-1MG
| ReadyTag anti-c-myc
| 1 mg
| BioXCell
| Western blot, ELISA, Flow cytometry
|
| Mouse
| N/
| Solicitar Precio
| Solicitar
|